Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Clinical trial NCT07039916 · RECRUITING
Trial details
- NCT number
- NCT07039916
- Sponsor
- Immunovant Sciences GmbH
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2027-12-01
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.